A coach that stays for the years after weight loss
LeKEEP by Oma Talk is ongoing coaching for anyone who has lost weight and wants to keep it off. The coach remembers what you said you would do, sees from your own scale and watch how it is going, and gets in touch when it helps. It is virtual care that carries on at home, long after the diet, the programme or the medication has ended. Built with the clinicians who treat obesity.
A few months ago we talked about walking to the station a few times a week. How has that been going?
Slipped the last couple of weeks. I think I forget in the morning rush.
Fair enough, mornings are busy. Want me to ping you the next few days as a reminder?
Could you do it the evening before? Then I can plan for it.
Sure. I’ll check in tomorrow evening.
The perfect support is not always affordable at scale
Most people regain weight once treatment ends. Sustained one-to-one coaching helps prevent it, but it costs one person’s time per person supported, every month, for years. So it gets rationed into a few intensive weeks and stops roughly when the long work starts. What is left is a leaflet, a discharge sheet and a number to call.
What keeps a conversation useful, month after month?
LeKEEP runs on the Oma Talk engine. It does four things that a human coach would otherwise have to keep in their head.
Nobody has to ask how the week went
Weight, activity and sleep arrive on their own from a scale and a wearable. Short optional check-ins ask how the person is feeling.
A commitment made in March might make sense to talk about in June
The coach remembers what was agreed and checks how it went against the person’s own data. It raises it again when the time is right.
The right conversation, at the right moment
The coach follows where each person is from week to week and month to month, and picks what the next conversation should be about. The person can always raise their own topics too.
Every recommendation is checked before anyone hears it
An independent check approves every recommendation, and every conversation is reviewed afterwards. A person steps in whenever one is needed.
Grounded in research, built with clinicians
The technology came out of a Copenhagen and Oxford research programme established in 2023 with a seed grant from the Novo Nordisk Foundation. Endocrinologists, GPs, health economists, statisticians and trial methodologists are part of the work.
The evidence for LeKEEP is being built to the standard expected of digital therapeutics (DTx), leading to a randomised controlled trial. The clinical research stays under university and hospital governance, so the product is evaluated by people with no commercial stake in the result.
Weight-loss treatment is growing fast. Keeping the result is the gap.
More people than ever are losing weight, on GLP-1 medication and in intensive programmes. Most will regain without ongoing support, and the organisations paying for the treatment want the result to last. LeKEEP is licensed to the organisations that already treat these patients and runs under their brand, as part of their home-based care. They keep the relationship with the patient and LeKEEP provides the ongoing coaching at home. It grows through their channels rather than through consumer marketing.
Pharma patient-support programmes
Need a maintenance pathway for patients who stop GLP-1 treatment.
GLP-1 telehealth services
Lose patients when treatment ends, and have nothing to offer them next.
Digital health platforms
Can embed LeKEEP in their own offering or run it under their own brand.
Health systems and payers
Pay for the treatment and need the result to last. The case is health-economic.
- Business-to-business licensing. Partners pay per enrolled user or per programme.
- Low cost per user. Daily coaching needs no human coach time, so the price works for public payers.
- Competitors become customers. Most digital weight-care companies solve weight loss. Few solve maintenance, and LeKEEP can sit behind their programmes.
- Denmark first, then the UK and Europe. European hosting and compliance count in a health buyer’s due diligence.
Pilot LeKEEP, or help take it further
We are looking for pilot partners in Denmark and the UK, and for investors who want to take LeKEEP into service.